학술논문
ERpS294 is a biomarker of ligand or mutational ERα activation and a breast cancer target for CDK2 inhibition
Document Type
Article
Author
Source
In: Oncotarget . (Oncotarget, 2017, 8(48):83432-83445)
Subject
Language
English
ISSN
19492553